Photocure ASA: Results for the second quarter and first half

/PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 115.9 million in the second quarter of 2023 (Q2 2022: NOK 99.9...

Related Keywords

China , United States , Norway , Oslo , Norwegian , America , Hexvix Cysview , Prnewswire Photocure , Janh Egberts , Erik Dahl , David Moskowitz , Robert Blatt , Dan Schneider , Karl Storz , Tolv Hillestad , Chairperson Of The Company Board Directors , Nomination Committee , Photocure Nomination Committee , Bladder Cancer Company , Oslo Stock Exchange , Corporate Communications Norway , North America , Chief Executive Officer , Blue Light Cystoscopy , Abuse Regulation , Norwegian Securities Trading , Group Controller , Photocure , Health Care Amp Hospitals , Otc , Mallcap , Medical Equipment , Medical Pharmaceuticals , Pharmaceuticals , Earnings ,